Novartis AG (NVS)

NYSE · Healthcare · Drug Manufacturers - General
$150.47-0.50%As of 2026-11-22 · USD
Last session low $150.24Last session high $152.70
52-week low $126.5052-week high $170.46
Market cap
$284.18B
Sector
Healthcare
P/E (TTM)
28.7x
Dividend yield
3.15%

Market data and research context for informational purposes. Not investment advice.

Technical indicators

Indicators from the 2026-11-20 daily bar; Bollinger %B and the average rows compare the latest price with those values. Prices in USD.

IndicatorValueReading
RSI (14)40.8In the neutral range (30 to 70)
MACD (12, 26, 9)0.86Below its signal line (2.50); histogram -1.65
Bollinger %B (20, 2)-8%Below the lower band (151.66 to 166.77)
SMA 20159.22Price is 5.5% below
SMA 50150.49Price is at the average
SMA 200152.55Price is 1.4% below
ATR (20)2.05% of priceAverage true range per day
52-week position55%In the middle of the 126.50 to 170.46 range

About Novartis AG

Novartis AG researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.

Latest fiscal yearEnded 2025-12-31: revenue of $56.67B and an operating margin of 31.1%.

More in Drug Manufacturers - General